| Literature DB >> 35888594 |
Yu-Pin Chen1,2, Wei-Chun Chang1,2, Tsai-Wei Wen3, Pei-Chun Chien1, Shu-Wei Huang1, Yi-Jie Kuo1,2.
Abstract
Background andEntities:
Keywords: fracture liaison service; hip fracture; outcomes; stratified care
Mesh:
Substances:
Year: 2022 PMID: 35888594 PMCID: PMC9315530 DOI: 10.3390/medicina58070875
Source DB: PubMed Journal: Medicina (Kaunas) ISSN: 1010-660X Impact factor: 2.948
Figure 1Fracture Liaison Service in Taipei Municipal Wanfang Hospital.
Figure 2Home visits for patients with hip fractures. (a,b) Instructing patients about home-based exercise; (c) protective device in the living environment, grab bars in the bathroom; (d) hazard in the living environment, obstacles on pathway; (e) environmental hazard, inadequate light.
Basic characteristics of patients in the pre-FLS and post-FLS groups.
| Variable | Pre-FLS ( | Post-FLS ( | |
|---|---|---|---|
| Age | 82.98 ± 8.20 | 80.67 ± 9.76 | 0.071 |
| Gender | 0.66 | ||
| Female | 81 (73.6%) | 83 (70.9%) | |
| Male | 27 (26.4%) | 34 (29.1%) | |
| BMI | 22.31 ± 3.74 | 21.58 ± 3.46 | 0.063 |
| Fracture type | 0.349 | ||
| Femoral neck fracture | 66 (60.0%) | 62 (53.0%) | |
| Peritrochanteric fracture | 44 (40.0%) | 55 (47.0%) | |
| Lesion side | 0.233 | ||
| Left | 52 (47.3%) | 65 (55.6%) | |
| Right | 58 (52.7%) | 52 (44.4%) | |
| CCI | 5.05 ± 1.74 | 4.87 ± 1.80 | 0.475 |
| Preoperative serum tests | |||
| Hemoglobin (g/dL) | 12.05 ±1.78 | 12.18 ± 1.74 | 0.924 |
| Creatinine (mg/dL) | 1.36 ±1.70 | 1.07 ± 0.96 | 0.477 |
| Sodium (mmol/L) | 137.01 ±3.77 | 136.62 ± 4.29 | 0.475 |
| Potassium (mmol/L) | 3.94 ±0.51 | 3.90 ± 0.46 | 0.617 |
| Surgical methods | 0.173 | ||
| Joint replacement | 48 (43.6%) | 40 (34.2%) | |
| Internal fixation | 62 (56.4%) | 77 (65.8%) | |
| Surgical delay from admission | 0.982 | ||
| Within 24 h | 66 (60%) | 70 (59.8%) | |
| 24–48 h | 32 (29.1%) | 35 (29.9%) | |
| >48 h | 12 (10.9%) | 12 (10.2%) | |
| Surgical time (h) | 71.61 ± 26.23 | 85.92 ± 54.62 | 0.073 |
| Surgical blood loss | 102.00 ± 91.95 | 106.39 ± 110.84 | 0.851 |
| Pre-fracture ADL | 82.36 ± 24.23 | 83.25 ± 23.78 | 0.959 |
Comparison of KPIs between the pre-FLS and post-FLS groups.
| KPIs | Pre-FLS | Post-FLS | |
|---|---|---|---|
| Assessment with DXA within 12 weeks after surgery | 92 (83.6%) | 102 (90.9%) | 0.449 |
| T-score | −3.93 ± 1.10 | −3.90 ± 1.12 | 0.84 |
| Sarcopenia screening | |||
| Handgrip strength (kg) | 14.52 ± 7.93 | 14.42 ± 12.50 | 0.382 |
| Muscle mass assessment with DXA | 80 (72.7%) | 96 (82.1%) | 0.093 |
| Muscle mass (ASMI, kg/m2) | 5.67 ± 1.04 | 5.70 ± 1.12 | 0.84 |
| Diagnosis of sarcopenia | 42 (53.2%) | 49 (51.3%) | 0.873 |
| Post-surgery physiotherapy consultation | 32 (29.1%) | 117(100%) | 0.000 |
| AOM use | |||
| Initiating treatment with AOMs | 32 (22.8%) | 74 (72.3%) | 0.000 |
| Prescription within 3 months after surgery | 24/32 (75%) | 67/74 (90.5%) | 0.071 |
| Denosumab | 10 (31.3%) | 46 (62.3%) | |
| Bisphosphonate | 11 (34.3%) | 19 (25.7%) | |
| Selective estrogen-receptor modulators | 7 (21.9%) | 2 (2.7%) | |
| Teriparatide | 4 (12.5%) | 7 (9.5%) | |
| Continuing AOMs for 1 year after fracture | 16 (14.5%) | 62 (53.0%) | |
| Nutrition supplements (i.e., calcium or vitamin D) | 16 (14.5%) | 65 (55.6%) | 0.000 |
| Receiving home visits | 0 | 66 (56.4%) | 0.000 |
Findings on home visits and changes thereafter.
| Home Visits after Hip Fracture Surgery | |
|---|---|
| Mean follow-up time after surgery (months) | 8.26 ± 3.40 |
| Mean age | 79.86 ± 9.52 |
| Environmental evaluation | |
| Indoor environmental hazards of falling | 54 (81.8%) |
| Inadequate light | 16 (24.2%) |
| Tripping hazards | 48 (72.7%) |
| Indoor environmental protection against falling | 26 (39.4%) |
| Antislip rubber mats in the bathroom | 22 (33.3%) |
| Grab bars on the path and in the bathroom | 10 (15.2%) |
| Changing environmental hazards after visits | 23/54 (42.6%) |
| Stop AOM use before home visits | 30 |
| Return to clinics for AOM treatment after home visits | 16/30 (53.3%) |
Comparison of 1-year outcomes between the pre-FLS and post-FLS groups.
| Outcomes | Pre-FLS ( | Post-FLS ( | |
|---|---|---|---|
| Refracture within the first year of surgery | 13 (11.8%) | 5 (4.9%) | 0.048 |
| Mortality within the first year of surgery | 17 (17.9%) | 12 (11.8%) | 0.225 |
| ADL at 1-year follow-up | 64.19 ± 34.17 | 75.61 ± 30.67 | 0.018 |